Oncotelic Therapeutics, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Oncotelic Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -16 %, a 57.6% increase year-over-year.
  • Oncotelic Therapeutics, Inc. annual Return On Assets for 2023 was -25.1 %, a 272% decline from 2022.
  • Oncotelic Therapeutics, Inc. annual Return On Assets for 2022 was 14.6 %.
  • Oncotelic Therapeutics, Inc. annual Return On Assets for 2021 was -39.8 %, a 0.3% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -25.1 -39.6 -272% Jan 1, 2023 Dec 31, 2023
2022 14.6 +54.3 Jan 1, 2022 Dec 31, 2022
2021 -39.8 -0.12 -0.3% Jan 1, 2021 Dec 31, 2021
2020 -39.6 +28 +41.4% Jan 1, 2020 Dec 31, 2020
2019 -67.6 -23.3 -52.6% Jan 1, 2019 Dec 31, 2019
2018 -44.3 +221 +83.3% Jan 1, 2018 Dec 31, 2018
2017 -265 -193 -269% Jan 1, 2017 Dec 31, 2017
2016 -71.8 -29.3 -68.8% Jan 1, 2016 Dec 31, 2016
2015 -42.5 -2.32 -5.77% Jan 1, 2015 Dec 31, 2015
2014 -40.2 +70.1 +63.6% Jan 1, 2014 Dec 31, 2014
2013 -110 +0.94 +0.85% Jan 1, 2013 Dec 31, 2013
2012 -111 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.